• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Alexander Cox, Niklas Klümper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020.

作者信息

Höglund Mattias

机构信息

Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden.

Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden.

出版信息

Eur Urol. 2023 Aug;84(2):e50. doi: 10.1016/j.eururo.2023.04.039. Epub 2023 May 31.

DOI:10.1016/j.eururo.2023.04.039
PMID:37268487
Abstract
摘要

相似文献

1
Re: Alexander Cox, Niklas Klümper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020.回复：亚历山大·考克斯、尼克拉斯·克吕珀、约翰内斯·施泰因等人。分子尿路上皮肿瘤细胞亚型在转移演变过程中保持稳定。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2023.03.020 。
Eur Urol. 2023 Aug;84(2):e50. doi: 10.1016/j.eururo.2023.04.039. Epub 2023 May 31.
2
Reply to Mattias Höglund's Letter to the Editor re: Alexander Cox, Niklas Klümper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020.回复马蒂亚斯·赫格隆德致编辑的信，内容涉及亚历山大·考克斯、尼克拉斯·克伦珀、约翰内斯·施泰因等人的《分子尿路上皮肿瘤细胞亚型在转移演变过程中保持稳定》。《欧洲泌尿外科杂志》待发表。https://doi.org/10.1016/j.eururo.2023.03.020 。
Eur Urol. 2023 Aug;84(2):e51-e52. doi: 10.1016/j.eururo.2023.05.016. Epub 2023 May 25.
3
Re: Niklas Klümper, Viktor Grünwald, Arndt Hartmann, et al. The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer. Eur Urol. 2025;87:388-390.
Eur Urol. 2025 Jan;87(1):e15-e16. doi: 10.1016/j.eururo.2024.08.037. Epub 2024 Sep 25.
4
Reply to Feng Qi's Letter to the Editor re: Niklas Klümper, Viktor Grünwald, Arndt Hartmann, et al. The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer. Eur Urol. 2024;86:388-390.
Eur Urol. 2025 Jan;87(1):e17-e18. doi: 10.1016/j.eururo.2024.09.019. Epub 2024 Sep 23.
5
Re: Logan G. Briggs, Chanan Reitblat, Paul A. Bain, et al. Prehabilitation Exercise Before Urologic Cancer Surgery: A Systematic and Interdisciplinary Review. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.05.015: Strategies for Effective Prehabilitation in Urologic Cancer.回复：洛根·G·布里格斯、查南·雷特布拉特、保罗·A·贝恩等。泌尿外科癌症手术前的预康复锻炼：一项系统的跨学科综述。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2021.05.015：泌尿外科癌症有效预康复的策略
Eur Urol. 2021 Dec;80(6):e139-e140. doi: 10.1016/j.eururo.2021.09.014. Epub 2021 Sep 23.
6
Reply to Kenta Ushida, Miho Shimizu, and Ryo Momosaki's Letter to the Editor re: Logan G. Briggs, Chanan Reitblat, Paul A. Bain, et al. Prehabilitation Exercise Before Urologic Cancer Surgery: A Systematic and Interdisciplinary Review. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.05.015. Strategies for Effective Prehabilitation in Urologic Cancer.
Eur Urol. 2021 Dec;80(6):e141-e142. doi: 10.1016/j.eururo.2021.09.015. Epub 2021 Sep 23.
7
Re: Evanguelos Xylinas, Michael Rink, Eugene K. Cha, et al. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.052.回复：埃万盖洛斯·克西利纳斯、迈克尔·林克、尤金·K·查等人。远端输尿管处理对上尿路尿路上皮癌根治性肾输尿管切除术后肿瘤学结局的影响。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2012.04.052 。
Eur Urol. 2012 Nov;62(5):e92-3. doi: 10.1016/j.eururo.2012.07.046. Epub 2012 Jul 31.
8
Re: Nicolaus F. Debatin, Elena Bady, Tim Mandelkow, et al. Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer. Eur Urol. 2024;86:42-51.回复：尼古劳斯·F·德巴廷、埃琳娜·巴迪、蒂姆·曼德尔科夫等人。尿路上皮癌中免疫细胞的预后影响及空间相互作用。《欧洲泌尿外科杂志》。2024年；86卷：42 - 51页。
Eur Urol. 2024 Nov;86(5):e127. doi: 10.1016/j.eururo.2024.05.031. Epub 2024 Jul 17.
9
Re: Richard J. Sylvester, Willem Oosterlinck, Sten Holmang, et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.050.
Eur Urol. 2016 Jan;69(1):e10-1. doi: 10.1016/j.eururo.2015.07.017. Epub 2015 Jul 26.
10
Re: Iver Nordentoft, Sia Viborg Lindskrog, Karin Birkenkamp-Demtröder, et al. Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma. Eur Urol. 2024;86:301-311.回复：伊弗·诺登托夫特、西亚·维堡·林茨克罗格、卡琳·比尔肯坎普 - 德姆特罗德等。尿路上皮癌患者循环肿瘤DNA肿瘤信息检测的全基因组突变分析。《欧洲泌尿外科杂志》。2024年；86卷：301 - 311页。
Eur Urol. 2025 Feb;87(2):e36-e37. doi: 10.1016/j.eururo.2024.07.021. Epub 2024 Aug 7.

引用本文的文献

1
Are primary tumors suitable for biomarker-guided treatment of metastatic urothelial cancer?原发性肿瘤是否适合生物标志物引导的转移性尿路上皮癌治疗？
Transl Androl Urol. 2024 Aug 31;13(8):1341-1345. doi: 10.21037/tau-24-112. Epub 2024 Aug 26.